Myeloma cells can promote osteoclastic activity rather than osteoclast recruitment in vitro; Evidence from the 5T2MM murine model of myeloma

Myeloma cells can promote osteoclastic activity rather than osteoclast recruitment in vitro; Evidence from the 5T2MM murine model of myeloma

ग्रंथसूची विवरण
मुख्य लेखकों:	Mueller, G, Vanderkerken, K, Russell, R, Croucher, P
स्वरूप:	Conference item
प्रकाशित:	2004

समान संसाधन

5T2MM murine myeloma cells and CD138+ve human myeloma cells promote osteoclastic activity rather than osteoclast formation in vitro
द्वारा: Mueller, G, और अन्य
प्रकाशित: (2004)

The Role of Myeloma Cells to Osteoclast Activation
द्वारा: Bahare Sadeghi, और अन्य
प्रकाशित: (2010-01-01)

Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease
द्वारा: Ersek, A, और अन्य
प्रकाशित: (2015)

The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma.
द्वारा: Shipman, C, और अन्य
प्रकाशित: (2000)

Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.
द्वारा: Edwards, C, और अन्य
प्रकाशित: (2007)

An In Vitro Model of Murine Osteoclast-Mediated Bone Resorption
द्वारा: Xiaoyue Sun, और अन्य
प्रकाशित: (2024-11-01)

Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease
द्वारा: Leng, H
प्रकाशित: (2019)

APOMINE (TM), a novel inhibitor of the meyalonate/isoprenoid pathway, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of the myeloma disease in vivo.
द्वारा: Croucher, P, और अन्य
प्रकाशित: (2002)

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
द्वारा: Mabilleau, G, और अन्य
प्रकाशित: (2009)

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.
द्वारा: Mabilleau, G, और अन्य
प्रकाशित: (2009)

Osteoprotegerin and the development of myeloma bone disease
द्वारा: Croucher, P, और अन्य
प्रकाशित: (2004)

Zoledronic Acid Inhibits the Capacity of Myeloid-Immune Suppressor Cells in Myeloma to Form Osteoclasts.
द्वारा: Zhuang, J, और अन्य
प्रकाशित: (2008)

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation
द्वारा: Dongzheng Gai, और अन्य
प्रकाशित: (2022-09-01)

Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1
द्वारा: Yu-Tzu Tai, और अन्य
प्रकाशित: (2018-08-01)

Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells
द्वारा: Tibullo eDaniele, और अन्य
प्रकाशित: (2015-10-01)

Bisphosphonates and in vivo models of multiple myeloma - Reply
द्वारा: Shipman, C, और अन्य
प्रकाशित: (2001)

Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
द्वारा: Croucher, P, और अन्य
प्रकाशित: (2000)

Bisphosphonates--mechanisms of action in multiple myeloma.
द्वारा: Shipman, C, और अन्य
प्रकाशित: (2000)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
द्वारा: Croucher, P, और अन्य
प्रकाशित: (2003)

The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease
द्वारा: Jing Fu, और अन्य
प्रकाशित: (2023-07-01)

TRPV2-induced Ca2+-calcineurin-NFAT signaling regulates differentiation of osteoclast in multiple myeloma
द्वारा: Hua Bai, और अन्य
प्रकाशित: (2018-10-01)

BISPHOSPHONATES AFFECT HUMAN OSTEOCLAST DEVELOPMENT IN VITRO
द्वारा: Mabilleau, G, और अन्य
प्रकाशित: (2010)

Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma.
द्वारा: Vanderkerken, K, और अन्य
प्रकाशित: (2003)

Osteoclasts in myeloma are derived from Gr-1+CD11b+mononuclear cells of the bone marrow niche
द्वारा: Zhuang, J, और अन्य
प्रकाशित: (2007)

Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells
द्वारा: Zhuang, J, और अन्य
प्रकाशित: (2012)

Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids
द्वारा: Xu, K, और अन्य
प्रकाशित: (2009)

Multi-Scale Agent-Based Multiple Myeloma Cancer Modeling and the Related Study of the Balance between Osteoclasts and Osteoblasts.
द्वारा: Minna Qiao, और अन्य
प्रकाशित: (2015-01-01)

A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts.
द्वारा: Maiko Matsushita, और अन्य
प्रकाशित: (2015-01-01)

Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells.
द्वारा: Junling Zhuang, और अन्य
प्रकाशित: (2012-01-01)

In vitro generation of mature human osteoclasts.
द्वारा: Hemingway, F, और अन्य
प्रकाशित: (2011)

In vitro generation of mature human osteoclasts.
द्वारा: Hemingway, F, और अन्य
प्रकाशित: (2011)

Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
द्वारा: Kudo, O, और अन्य
प्रकाशित: (2002)

The Effects of Forodesine in Murine and Human Multiple Myeloma Cells
द्वारा: Liesbeth Bieghs, और अन्य
प्रकाशित: (2010-01-01)

Effect of amorphous silica nanoparticles on <it>in vitro </it>RANKL-induced osteoclast differentiation in murine macrophages
द्वारा: Nagano Kazuya, और अन्य
प्रकाशित: (2011-01-01)

Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.
द्वारा: Matilda H-C Sheng, और अन्य
प्रकाशित: (2012-01-01)

Osteoclasts and Microgravity
द्वारा: John Kelly Smith
प्रकाशित: (2020-09-01)

Estrogen receptor gene expression in osteoclasts loss with osteoclast maturation.
द्वारा: Oreffo, R, और अन्य
प्रकाशित: (1997)

Osteoclast Activation and Inflammatory Bone Diseases: Focusing on Receptors in Osteoclasts
द्वारा: Zhao W, और अन्य
प्रकाशित: (2025-03-01)

NK cells support osteoclast formation in vitro
द्वारा: Owen, S, और अन्य
प्रकाशित: (2004)

Activated T lymphocytes support osteoclast formation in vitro.
द्वारा: Horwood, N, और अन्य
प्रकाशित: (1999)